eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hyperthermia |
| Comorbidity | C0376545|hematologic malignancies |
| Sentences | 11 |
| PubMedID- 23288950 | Methods: this study compares proadm to pct as diagnostic and prognostic biomarkers of infection in febrile patients with hematologic malignancies (hms). |
| PubMedID- 22627304 | A comparative analysis of meropenem and doripenem in febrile patients with hematologic malignancies: a single-center retrospective study. |
| PubMedID- 25013718 | Intensive serial biomarker profiling for the prediction of neutropenic fever in patients with hematologic malignancies undergoing chemotherapy: a pilot study. |
| PubMedID- 22340222 | Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies: an open-lable, multicenter, observational trial in a chinese cohort. |
| PubMedID- 20509945 | febrile neutropenia (fn) in patients with hematologic malignancies is characterized by increased susceptibility to sepsis complications, and a higher risk of septic shock, with mortality ranging from 2-21% [16]. |
| PubMedID- 23742830 | The significance of serum urokinase plasminogen activation receptor (supar) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies. |
| PubMedID- 22522755 | The aim of this study was to describe the chest ct findings of confirmed h1n1 virus in a small series of neutropenic febrile patients with hematologic malignancies and solid tumors. |
| PubMedID- 24693464 | A recent study of febrile patients with hematologic malignancies reported that proadm could predict localized bacterial infections and differentiate sepsis from sirs [65]. |
| PubMedID- 24596542 | Adverse events, which occurred in five patients (21.7%), were mild or moderate abnormal liver enzymes, that did not require discontinuation of the study drug, and all resolved after finishing micafungin.27 although the number of patients in this study was small, monotherapy with micafungin for febrile neutropenia in patients with hematologic malignancies appeared to be safe and efficacious. |
| PubMedID- 25861154 | Al shuaibi investigated pct levels in febrile patients with hematologic malignancies at the onset of fever and found higher initial pct levels in patients with definite sepsis and systemic inflammatory response syndrome (sirs) compared to those patients without documented infections. |
| PubMedID- 22058202 | Conclusions: based on the high negative predictive value of this diagnostic and therapeutic approach in persistent febrile neutropenia patients with hematologic malignancies or patients who have received a hematopoietic stem cell transplant, the approach is useful for identifying patients who are not likely to develop invasive fungal infection and do not, therefore, require antifungal therapy. |
Page: 1